Trial intelligence / Profile preview

Effect of Amlodipine on FGF-23 in Diabetic Proteinuria

NCT01738945Phase 4Completed

Sponsor
Gulhane School of Medicine
Start
Feb 2008
Primary completion
May 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of amlodipine in diabetic nephropathy (DN), sponsored by Gulhane School of Medicine. Started Feb 2008; status: completed.

02

Drugs

amlodipine
03

Conditions

diabetic nephropathy (DN)

Beyond the preview

Go deeper on NCT01738945.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01738945.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call